Show simple item record

dc.contributor.authorBach, Anthea C
dc.contributor.authorLo, Kelvin Se
dc.contributor.authorPathirana, Thanya
dc.contributor.authorGlasziou, Paul P
dc.contributor.authorBarratt, Alexandra L
dc.contributor.authorJones, Mark A
dc.contributor.authorBell, Katy Jl
dc.date.accessioned2019-11-25T23:36:37Z
dc.date.available2019-11-25T23:36:37Z
dc.date.issued2020
dc.identifier.issn0025-729X
dc.identifier.doi10.5694/mja2.50376
dc.identifier.urihttp://hdl.handle.net/10072/389267
dc.description.abstractOBJECTIVES: To calculate lifetime risks of cancer diagnosis and cancer-specific death, adjusted for competing mortality, and to compare these estimates with the corresponding risks published by the Australian Institute of Health and Welfare (AIHW). DESIGN, SETTING: Analysis of publicly available annual AIHW data on age-specific cancer incidence and mortality - for breast cancer, colorectal cancer, prostate cancer, melanoma of the skin, and lung cancer - and all-cause mortality in Australia, 1982-2013. OUTCOME MEASURES: Lifetime risks of cancer diagnosis and mortality (to age 85), adjusted for competing mortality. RESULTS: During 1982-2013, AIHW estimates were consistently higher than our competing mortality-adjusted estimates of lifetime risks of diagnosis and death for all five cancers. Differences between AIHW and adjusted estimates declined with time for breast cancer, prostate cancer, colorectal cancer, and lung cancer (for men only), but remained steady for lung cancer (women only) and melanoma of the skin. In 2013, the respective estimated lifetime risks of diagnosis (AIHW and adjusted) were 12.7% and 12.1% for breast cancer, 18.7% and 16.2% for prostate cancer, 9.0% and 7.0% (men) and 6.4% and 5.5% (women) for colorectal cancer, 7.5% and 6.0% (men) and 4.4% and 4.0% (women) for melanoma of the skin, and 7.6% and 5.8% (men) and 4.5% and 3.9% (women) for lung cancer. CONCLUSION: The method employed in Australia to calculate the lifetime risks of cancer diagnosis and mortality overestimates these risks, especially for men.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherWiley-Blackwell Publishing Asia
dc.publisher.placeAustralia
dc.relation.ispartofjournalMedical Journal of Australia
dc.subject.fieldofresearchOncology and Carcinogenesis
dc.subject.fieldofresearchMedical and Health Sciences
dc.subject.fieldofresearchPsychology and Cognitive Sciences
dc.subject.fieldofresearchcode1112
dc.subject.fieldofresearchcode11
dc.subject.fieldofresearchcode17
dc.subject.keywordsBiostatistics
dc.subject.keywordsData collection
dc.subject.keywordsHealth policy
dc.subject.keywordsMass screening
dc.subject.keywordsNeoplasms, epidemiology
dc.titleIs the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationBach, AC; Lo, KS; Pathirana, T; Glasziou, PP; Barratt, AL; Jones, MA; Bell, KJ, Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk., Medical Journal of Australia, 2019
dcterms.dateAccepted2019-06-24
dc.date.updated2019-11-19T03:57:08Z
gro.description.notepublicThis publication has been entered into Griffith Research Online as an Advanced Online Version
gro.hasfulltextNo Full Text
gro.griffith.authorPathirana, Thanya I.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record